within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M03B_MuscleRelaxantsCentrallyActingAgents.M03BA02_Carisoprodol;

model Carisoprodol
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 1,
    Cl = 6.972222222222223e-06,
    adminDuration = 600,
    adminMass = 350 / 1000000,
    adminCount = 1,
    Vd = 0.000992,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.01155,
    Tlag = 0);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Carisoprodol</td></tr><tr><td>ATC code:</td><td>M03BA02</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>350</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.992</td><td>L</td></tr>
    <tr><td>clearance:</td><td>25.1</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Carisoprodol is a centrally acting skeletal muscle relaxant that blocks pain sensations between the nerves and the brain. It is primarily used for the short-term relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Carisoprodol is a controlled substance due to its potential for abuse and dependence; in many countries, its use has been reduced or discontinued. In the United States, carisoprodol remains approved for prescription use for up to two or three weeks at a time.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following single oral administration.</p><h4>References</h4><ol><li><p>Heltsley, R, et al., &amp; Cone, EJ (2011). Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs. <i>Journal of analytical toxicology</i> 35(8) 529–540. DOI:<a href=\"https://doi.org/10.1093/anatox/35.8.529\">10.1093/anatox/35.8.529</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22004671/\">https://pubmed.ncbi.nlm.nih.gov/22004671</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.M.M03BA02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Carisoprodol;
